title: Gadolinium and nephrogenic systemic fibrosis: an update.
abstract: Nephrogenic systemic fibrosis (NSF) is a multisystem disease seen exclusively in patients with renal impairment. It can be severely debilitating and sometimes fatal. There is a strong association with gadolinium-based contrast agents used in magnetic resonance imaging (MRI). Risk factors include renal impairment and proinflammatory conditions, e.g. major surgery and vascular events. Although there is no single effective treatment for NSF, the most successful outcomes are seen following restoration of renal function, either following recovery from acute kidney injury or following renal transplantation. There have been ten biopsy-proved pediatric cases of NSF, with no convincing evidence that children have a significantly altered risk compared with the adult population. After implementation of guidelines restricting the use of gadolinium-based contrast agents in at-risk patients, there has been a sharp reduction in new cases and no new reports in children. Continued vigilance is recommended: screening for renal impairment, use of more stable gadolinium chelates, consideration of non-contrast-enhanced MRI or alternative imaging modalities where appropriate.
authors.affiliation: Department of Radiology, St George's Hospital NHS Trust, Blackshaw Road, London, SW17 0QT, UK, alweller@gmail.com.
authors.forename: Alex
authors.initials: A
authors.lastname: Weller
authors.forename: Joy L
authors.initials: JL
authors.lastname: Barber
authors.forename: Oystein E
authors.initials: OE
authors.lastname: Olsen
mesh_terms: D000328:Adult; D002648:Child; D003287:Contrast Media / Q000009:adverse effects*; D005682:Gadolinium / Q000009:adverse effects*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D054989:Nephrogenic Fibrosing Dermopathy / Q000139:chemically induced* / Q000473:pathology*; D012307:Risk Factors
chemical_list: D003287:Contrast Media; D005682:Gadolinium